Certain people taking Mounjaro or Wegovy told ‘stop’ - rules are 'clear'
Women using a widely prescribed treatment have been given a reminder that could affect plans for the future Ethan Evans GAU Writer 12:07, 17 Nov 2026 A warning has been issued to women using weight-loss and diabetes injections, with health officials highlighting an important risk that can be overlooked when starting treatment. The advice is relevant to patients across Scotland, including those using medicines privately as well as through NHS services. The reminder comes from the Medicines and Healthcare products Regulatory Agency (MHRA), which has published guidance on contraception and GLP-1 medicines. It covers treatments including Mounjaro, Wegovy, Ozempic, Saxenda and Victoza, and says they should not be taken during pregnancy, while trying to conceive or while breastfeeding. Professor Cathy Harrison, Northern Ireland’s Chief Pharmaceutical Officer, backed the reminder in a statement issued by the Department of Health. She said: "With use of weight loss medication on the rise in Northern Ireland and across the UK, it is timely that MHRA have issued this reminder to women who use these medications. "The reminder is clear; do not take GLP-1 medicines if you are pregnant, trying to get pregnant or breastfeeding. If you get pregnant while using them, you should speak to your healthcare professional and stop the medicine as soon as possible. "All patients, on any form of medication, should read the patient information leaflet, or speak with a healthcare professional as part of the prescribing process." Professor Harrison is a qualified pharmacist and has been Northern Ireland’s Chief Pharmaceutical Officer since 2019, providing senior professional advice on medicines and pharmacy policy. She was named an Honorary Professor of Practice at Queen’s University Belfast in 2023, recognising her leadership and contribution to pharmacy practice. For people in Scotland, NHS inform says tirzepatide, sold as Mounjaro, can affect how the body absorbs some medicines, including oral contraception. It advises using additional barrier contraception, such as condoms, for four weeks after starting treatment and for four weeks after each dose increase. Ensure our latest Health headlines always appear at the top of your Google Search by making us a Preferred Source. Click here to activate or add us as Preferred Source in your Google search settings The Scottish Government ’s prescribing guidance also highlights contraception advice for people using Mounjaro. Women taking the pill should discuss suitable precautions with their prescriber, including whether a non-oral method would be more appropriate. Article continues below The MHRA says there is not enough safety information to know whether GLP-1 medicines could harm an unborn baby. Its guidance states that Mounjaro should be stopped at least one month before someone tries to become pregnant, while semaglutide medicines such as Wegovy and Ozempic should be stopped at least two months beforehand. NHS Scotland guidance and the MHRA both stress the importance of discussing treatment with a healthcare professional. Anyone who becomes pregnant while using Mounjaro should contact their prescriber promptly and follow medical advice about stopping the medicine.